Past, present, and future of CRISPR genome editing technologies
Genome editing has been a transformative force in the life sciences and human medicine, offering unprecedented opportunities to dissect complex biological processes and treat the underlying causes of many genetic diseases. CRISPR-based technologies, with their remarkable efficiency and easy programmability, stand at the forefront of this revolution. In this Review, we discuss the current state of CRISPR gene editing technologies in both research and therapy, highlighting limitations that constrain them and the technological innovations that have been developed in recent years to address them. Additionally, we examine and summarize the current landscape of gene editing applications in the context of human health and therapeutics. Finally, we outline potential future developments that could shape gene editing technologies and their applications in the coming years.
WOS:001209225700001
2024-02-29
187
5
1076
1100
REVIEWED
Funder | Grant Number |
Peter und Traudl Engelhorn Stiftung | |
Swiss National Science Foundation | 31003A_182567 |
European Research Council (ERC) | ERC-CoG-820152 |